AU2016204414A1 - Stable digestive enzyme compositions - Google Patents

Stable digestive enzyme compositions

Info

Publication number
AU2016204414A1
AU2016204414A1 AU2016204414A AU2016204414A AU2016204414A1 AU 2016204414 A1 AU2016204414 A1 AU 2016204414A1 AU 2016204414 A AU2016204414 A AU 2016204414A AU 2016204414 A AU2016204414 A AU 2016204414A AU 2016204414 A1 AU2016204414 A1 AU 2016204414A1
Authority
AU
Australia
Prior art keywords
digestive enzyme
compositions
enzyme compositions
less
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2016204414A
Other versions
AU2016204414B2 (en
Inventor
Luigi Mapelli
Marco Marconi
Giovanni Ortenzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Therapeudics LLC
Original Assignee
Aptalis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012202620A external-priority patent/AU2012202620B2/en
Priority claimed from AU2014203364A external-priority patent/AU2014203364B2/en
Application filed by Aptalis Pharma Ltd filed Critical Aptalis Pharma Ltd
Priority to AU2016204414A priority Critical patent/AU2016204414B2/en
Publication of AU2016204414A1 publication Critical patent/AU2016204414A1/en
Application granted granted Critical
Publication of AU2016204414B2 publication Critical patent/AU2016204414B2/en
Assigned to Allergan Therapeutics LLC reassignment Allergan Therapeutics LLC Request for Assignment Assignors: APTALIS PHARMA LIMITED
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • Y02W90/11—

Abstract

STABLE DIGESTIVE ENZYME COMPOSITIONS Compositions disclosed herein, comprising at least one digestive enzyme (e.g., pancrelipase), are useful for treating or preventing disorders associated with digestive enzyme deficiencies. The compositions may comprise a plurality of coated particles, each of which is comprised of a core coated with an enteric coating comprising at least one enteric polymer and 4-10% of at least one alkalinizing agent, or have moisture contents of about 3% or less, water activities of about 0.6 or less, or exhibit a loss of activity of no more than about 15% after six months of accelerated stability testing.
AU2016204414A 2007-02-20 2016-06-27 Stable digestive enzyme compositions Ceased AU2016204414B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016204414A AU2016204414B2 (en) 2007-02-20 2016-06-27 Stable digestive enzyme compositions

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US60/902,091 2007-02-20
US60/902,092 2007-02-20
US60/902,093 2007-02-20
AU2012202620A AU2012202620B2 (en) 2007-02-20 2012-05-03 Stable digestive enzyme compositions
AU2014203364A AU2014203364B2 (en) 2007-02-20 2014-06-20 Stable digestive enzyme compositions
AU2016204414A AU2016204414B2 (en) 2007-02-20 2016-06-27 Stable digestive enzyme compositions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2014203364A Division AU2014203364B2 (en) 2007-02-20 2014-06-20 Stable digestive enzyme compositions

Publications (2)

Publication Number Publication Date
AU2016204414A1 true AU2016204414A1 (en) 2016-07-14
AU2016204414B2 AU2016204414B2 (en) 2018-02-08

Family

ID=56682839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016204414A Ceased AU2016204414B2 (en) 2007-02-20 2016-06-27 Stable digestive enzyme compositions

Country Status (1)

Country Link
AU (1) AU2016204414B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
AU2016204414B2 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
WO2008102264A3 (en) Stable digestive enzyme compositions
Grover et al. Acylase‐containing polyurethane coatings with anti‐biofilm activity
Ervin et al. Relationship between the gut microbiome and systemic chemotherapy
WO2008060813A3 (en) High affinity antibody antagonists of interleukin-13 receptor alpha 1
ATE418329T1 (en) PANCREATIN MICROPELLETS SUITABLE FOR ENTERIC JUICE RESISTANT COATINGS
GB2407822A (en) Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
RS52891B (en) Gastroresistant pharmaceutical formulations containing rifaximin
WO2011163483A3 (en) Polymers for biomaterials and therapeutics
WO2009021986A8 (en) Seed treatment compositions and methods
WO2000071507A3 (en) INHIBITORS OF FACTOR Xa
WO2002026944A3 (en) METHODS AND COMPOSITIONS EMPLOYING A NOVEL STEAROYL-CoA DESATURASE-hSCD5
MX2007008141A (en) Pharmaceutical composition of acid labile substances.
YU401A (en) Agents with an antidepressive effect
WO2005123034A3 (en) Microparticulate systems for the oral administration of biologically active substances
AR078291A1 (en) COMPOSITIONS OF PANCREATIC ENZYMES AND METHODS TO TREAT PANCREATITIS AND PANCREATIC INSUFFICIENCY
RS52914B (en) Amorphous solid dispersions of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5,-dihydro-4h-pyridazino (4,5-b) indole-1-acetamide
WO2008019069A3 (en) Enzymatic aqueous acylation
AU2016204414A1 (en) Stable digestive enzyme compositions
AU2014203364B2 (en) Stable digestive enzyme compositions
Pompilio et al. Myroides odoratimimus forms structurally complex and inherently antibiotic-resistant biofilm in a wound-like in vitro model
WO2008073779A3 (en) Compositions and methods for treating seizures
WO2007109713A3 (en) Dosage forms having a randomized coating
WO2000057871A3 (en) Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof
Monticone et al. Demethyl fruticulin A (SCO‐1) causes apoptosis by inducing reactive oxygen species in mitochondria
DE69901835D1 (en) HEAT-CURABLE RESINY BINDING COMPOSITIONS, THEIR PRODUCTION AND THEIR USE AS COATINGS

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: ALLERGAN THERAPEUTICS LLC

Free format text: FORMER OWNER(S): APTALIS PHARMA LIMITED

MK14 Patent ceased section 143(a) (annual fees not paid) or expired